An intervention to improve pneumococcal vaccination uptake in high risk 50-64 year olds vs. expanded age-based recommendations: an exploratory cost-effectiveness analysis

• Main Authors: Angela R. Wateska (Author), Mary Patricia Nowalk (Author), Chyongchiou J. Lin (Author), Lee H. Harrison (Author), William Schaffner (Author), Richard K. Zimmerman (Author), Kenneth J. Smith (Author)
• Format: Book
• Published: Taylor & Francis Group, 2019-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

In the U.S., pneumococcal polysaccharide vaccine (PPSV23) uptake among high-risk adults aged <65 years is consistently low and improvement is needed. One barrier to improved vaccine coverage is the complexity of the adult vaccination schedule. This exploratory analysis compared the cost-effective...